Aqupharm 1 0.9% w/v Solution for Infusion

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Sodium Chloride

Disponible depuis:

Animalcare Ltd

Code ATC:

QB05BB01

DCI (Dénomination commune internationale):

Sodium Chloride

forme pharmaceutique:

Solution for infusion

Type d'ordonnance:

POM-V - Prescription Only Medicine – Veterinarian

Groupe thérapeutique:

Cats, Dogs

Domaine thérapeutique:

Replacement Agent

Statut de autorisation:

Expired

Date de l'autorisation:

1988-06-07

Résumé des caractéristiques du produit

Revised: July 2015
AN: 01566/2014
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Aqupharm 1 0.9 % w/v Solution for infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS
Sodium Chloride
0.9% w/v
IONS
Sodium
150 mmol/l
Chloride
150 mmol/l
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for infusion
A clear, colourless solution, free from particulate matter
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dehydration to correct water and electrolyte
depletion.
It is indicated in severe vomiting of acute onset where excessive
losses of
chloride ions occur and those conditions where the lodgement of
foreign
bodies interfere with ingestion, i.e. where there is vomiting and/or
endotoxic shock.
Once these losses have been replaced, it should be substituted by
Aqupharm No. 18 to avoid the administration of an excess of sodium
ions.
Additional oral potassium supplements may be required with protracted
use.
Revised: July 2015
AN: 01566/2014
Page 2 of 6
4.3
CONTRAINDICATIONS
Sodium overload may occur in cases with myocardial and renal damage.
It
should also be appreciated that in the period following surgical
interference or severe trauma there may be an inability to excrete
excessive sodium.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In evaluating an animal for possible fluid therapy the state of
hydration,
electrolyte balance, acid-base balance, renal function and caloric
balance
should be considered. Evaluation will be based on history, physical
examination and laboratory testing.
The solution is not suitable for protracted use unless there is heavy
and
continued loss of electrolytes. The difficulty arises from a danger of
potassium imbalance. In cases of potassium deficiency the
administration
of normal saline will increase potassium loss. Where such deficiency
is
known to occur it may be necessary to give oral potassium supplements.
4.5
SPECIAL P